1. Identify potential pro’s and con’s of using published norms to flag abnormal performance;
2. Describe the challenges of interpreting longitudinal change (particularly preclinical);
3. Discuss the difference between unconditional and conditional norms;
4. List at least one biomarker that is elevated in people with evidence of subclinical cognitive decline.
Session date:
11/22/2024 - 10:00am to 11:00am CST
Location:
Virtual
United States
See map: Google Maps
- 1.00 APA CE Credits
- 1.00 University of Wisconsin–Madison Continuing Education Hours
- 1.00 Approved for AMA PRA Category 1 Credit™
Add to calendar:
Discloser List CME Internal Report